ARCHIVES

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 21 No. 33 | August 18, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings For Feb., March Listed

January 25, 1991

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

Austria Has highest Cancer Rate, Little NCI Support

June 17, 1977

Moves Forward With Approval From BSA

November 22, 2013

NCI Cooperative Group Clinical Trials Approved

September 25, 2009

Congress Asked To Equalize Cuts, Add $20 million For Centers

April 25, 1980